Zentalis Pharmaceuticals (ZNTL) Intangibles (2019 - 2021)

Zentalis Pharmaceuticals' Intangibles history runs 3 years deep, the most recent figure standing at $8.8 million for Q2 2021.

• On a quarterly basis, Intangibles changed 0.0% year-over-year to $8.8 million in Q2 2021; TTM through Jun 2021 was $8.8 million, a 0.0% change from a year earlier, with the FY2020 full-year figure at $8.8 million, changed 0.0% from the prior year.
• Intangibles was little changed at $8.8 million in Q2 2021 per ZNTL's latest filing, from $8.8 million in the prior quarter.
• Across five years, Intangibles topped out at $8.8 million in Q4 2019 and bottomed at $8.8 million in Q4 2019.
• The 3-year median for Intangibles is $8.8 million (2019), against an average of $8.8 million.
• Biggest YoY gain for Intangibles was 0.0% in 2020; the steepest drop was 0.0% in 2020.
• Year by year, Intangibles stood at $8.8 million in 2019, then changed by 0.0% to $8.8 million in 2020, then changed by 0.0% to $8.8 million in 2021.
• Per Business Quant, the three latest ZNTL Intangibles figures stand at $8.8 million (Q2 2021), $8.8 million (Q1 2021), and $8.8 million (Q4 2020).